Alcohol intake, beverage type, and lung function: a multicohort study of Chinese adults
We aimed to investigate whether alcohol intake contributes to lung function levels and which beverage type may have an effect. We investigated 3742 participants from the Wuhai-Zhuhai Cohort and 12,526 participants from the Dongfeng-Tongji Cohort, and they were followed up for 3 and 5 years, respectively.
Information on the type and daily amount of alcohol intake was collected through face-to-face interviews. Lung function was measured by trained physicians using electronic spirometers. Compared with nondrinkers, moderate alcohol intake was significantly associated with a 70.03 and 74.92 mL increase in FEV1 and FVC, respectively (P < 0.05), after adjusting for covariates.
With regard to beverage type, red wine was associated with a 105.31 and 98.91 mL increase in FEV1 and FVC, respectively (P < 0.05). Moderate alcohol intake was also associated with a 53.37 and 66.17 mL increase in FEV1 and FVC for liquor, respectively, and a 106.90 and 103.62 mL increase for red wine (all Ps < 0.05). In the longitudinal analyses, moderate alcohol intake and red wine were associated with a 67.77 and 103.77 mL increase in FVC, respectively (P < 0.05).
Moderate alcohol intake is associated with increased lung function, especially for red wine. Further studies are needed to investigate the potential mechanism.
Additional Info
-
Authors
Wang D.; Cao L.; Zhou M.; Ma J.; Wang B.; Yuan J.; Chen W. -
Issue
Ann N Y Acad Sci . 2022 Jan 25. doi: 10.1111/nyas.14744 -
Published Date
25 january 2022
Related items
- Mediterranean diet: definitions, health effects and metabolic pathways – evidence and future directions
- Interpreting the Evidence on Wine Consumption and Health: A Narrative Review of the J-Shaped Association and Contemporary Alcohol Guidelines
- Attitudes Toward Cancer and Heart Disease Warning Labels on Alcoholic Beverages in the United States
- Age at first drink below 19 years and all-cause mortality in Chinese older adults: a 10-year prospective cohort study
- Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial